Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	52.84B -18.0%
Revenue (ttm)	44.06B +4.3%
Net Income	3.50B -1.8%
EPS	2.00 -1.7%
Shares Out	1.75B
PE Ratio	15.09
Forward PE	11.80
Dividend	0.93 (3.09%)
Ex-Dividend Date	Sep 18, 2025

Volume	7,966,310
Average Volume	13,515,389
Open	31.00
Previous Close	30.13
Day's Range	29.38 - 31.00
52-Week Range	29.39 - 47.36
Beta	0.20
RSI	22.05
Earnings Date	Apr 24, 2026

About Huadong Medicine

Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It offers Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, medical cosmetology, and antibiotic drugs, as well as medical equipment. The company's products include gastrointestinal agents, APIs, and other products. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 19,095
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2025, Huadong Medicine's revenue was 43.61 billion, an increase of 4.07% compared to the previous year's 41.91 billion. Earnings were 3.41 billion, a decrease of -2.78%.